# Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Study · id `cardio:ct-nct05845710` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05845710](<https://clinicaltrials.gov/study/NCT05845710>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05845710

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

## Technical summary

Registry record NCT05845710. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-05 (actual); primary completion 2025-08-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 178 participants (enrolled count; ClinicalTrials.gov record NCT05845710, source copy `cardio:ctgov-nct05845710-2026-03-06`, retrieved 2026-10-31)
- Started: 2023-10-05 (actual) (ClinicalTrials.gov record NCT05845710, source copy `cardio:ctgov-nct05845710-2026-03-06`, retrieved 2026-10-31)
- Primary completion: 2025-08-12 (actual) (ClinicalTrials.gov record NCT05845710, source copy `cardio:ctgov-nct05845710-2026-03-06`, retrieved 2026-10-31)
- Completion: 2025-08-12 (actual) (ClinicalTrials.gov record NCT05845710, source copy `cardio:ctgov-nct05845710-2026-03-06`, retrieved 2026-10-31)
- Countries: United States; France (ClinicalTrials.gov record NCT05845710, source copy `cardio:ctgov-nct05845710-2026-03-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05845710-2026-03-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
- Condition: Carotid Stenosis
- Condition: Carotid Artery Diseases
- Intervention (Device): Neuroguard IEP Direct System
- Lead sponsor: Contego Medical, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Yale Cardiovascular Research Group
- Collaborator class: OTHER
- Collaborator: CardioMed Device Consultants, LLC
- Collaborator class: INDUSTRY
- Collaborator: Advance Research Associates
- Collaborator class: OTHER
- Collaborator: iMedNet
- Collaborator class: UNKNOWN
- Collaborator: AG Mednet
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry lists this organization as the lead sponsor: Contego Medical, Inc. (`cardio:org-contego-medical-inc`)
- Registry lists this organization as a collaborator: Yale Cardiovascular Research Group (`cardio:org-yale-cardiovascular-research-group`)
- Registry lists this organization as a collaborator: CardioMed Device Consultants, LLC (`cardio:org-cardiomed-device-consultants-llc`)
- Registry lists this organization as a collaborator: Advance Research Associates (`cardio:org-advance-research-associates`)

## Provenance

Content hash: 3365a51b58127310137bc5681a86eed046bc4d912de51443f16f78ad71965eef
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
